NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation
Authors:
- 17 January 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 698, 149536
Abstract
No abstract availableKeywords
Funding Information
- Key Research and Development Projects of Shaanxi Province (2021SF-125)
This publication has 26 references indexed in Scilit:
- NRF2 and the Hallmarks of CancerCancer Cell, 2018
- Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2016
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcriptionNature Communications, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Elevation of HO-1 Expression Mitigates Intestinal Ischemia-Reperfusion Injury and Restores Tight Junction Function in a Rat Liver Transplantation ModelOxidative Medicine and Cellular Longevity, 2015
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapyNature Medicine, 2014
- Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistanceFree Radical Biology and Medicine, 2013
- Type I interferon is selectively required by dendritic cells for immune rejection of tumorsJournal of Experimental Medicine, 2011
- Increased Endothelial Mitogen-Activated Protein Kinase Phosphatase-1 Expression Suppresses Proinflammatory Activation at Sites That Are Resistant to AtherosclerosisCirculation Research, 2008
- Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 inductionJournal of Clinical Investigation, 2005